Soliton – Consensus Indicates Potential 91.2% Upside

Broker Ratings

Soliton found using ticker (SOLY) now have 3 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The range between the high target price and low target price is between 22 and 12 and has a mean target at 16. With the stocks previous close at 8.37 this is indicating there is a potential upside of 91.2%. The day 50 moving average is 8.4 and the 200 day moving average is 8.22. The market capitalisation for the company is $177m. You can visit the company’s website by visiting:

Soliton, a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers product for the removal of tattoos. It also develops product for cellulite reduction, fibrotic scar treatment, and other indications. The company was founded in 2012 and is based in Houston, Texas.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits

Good news travels fast (but only if you make that happen). Share on:

Share on twitter
Share on linkedin
Share on facebook
Share on email
Share on reddit

AIM All Share Index